USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ...

A recently developed cancer treatment called chimeric antigen receptor T-cell therapy (CAR T-cell therapy, for short) offers hope to people whose diffuse large B-cell lymphoma (DLBCL) has proved ...

Encompass Health tapped Patrick Tuer to serve as its first COO. He has held various leadership positions, including group ...

DLBCL is almost always treated first with chemotherapy and drugs called monoclonal antibodies that attack cancer cells; 60% to 70% of patients go into remission after this. For those who don’t ...

Adoptive Cell Transfer (ACT) includes a class of immunotherapy approaches to treat cancer.  This procedure focuses on a ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

In a new study published in Science Bulletin, researchers from West China Hospital of Sichuan University present the largest ...

Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow ...